Home › Studies › PRJEB56830
PRJEB56830 ERP141795

Isocaloric high- vs low-protein diet RCT, Netherlands/France

Isocaloric dietary protein intervention

430 gut metagenome samples from participants in a multi-center randomized controlled trial comparing isocaloric high-protein (n=79) versus low-protein (n=73) diets over 12 weeks, from the Netherlands and France. machine-written summary

430 samples · 430 runs · NL, FR · Age unknown · 2024 · 6.19 Gbp / sample

Sources
✓Sequence archive 2,988○Abstract / description✓Full text 2,150○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive2,988 sample values (country, diet, diet detail, intervention, intervention detail, subject id, timepoint)
○ Abstract / descriptionread; no usable statement
✓ Full text2,150 sample values (antibiotic exposure, health condition, health condition detail, medication, medication detail) · PMC10432813
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention · arms resolved

RControlled / prescribed diet or feeding regimen: 148 people · 288 samplesdiet 148 people · 288 samplesControl / pre-intervention baseline (sample level only): 139 people · 142 samplesno intervention 139 people · 142 samples
randomised to parallel arms

134 people have samples in more than one arm.

Controlled / prescribed diet or feeding regimen design randomized_controlled_trial · High-protein vs low-protein isocaloric diet, 12 weeks

“randomized to follow either a HP” — bioproject.description (study level; per-sample arms are in the intervention column below)

Samples at a glance
2 countries
Age
unknown430
Condition
type2_diabetes430
Country
NL257
FR173
Body site
primary430
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 428 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 2 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 6.19 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

148 of 153 people sampled more than once (418 samples; median 3, up to 3 per person) · follow-up median 3 mo (max 3 mo) · median interval between samples 42 d (time from timepoint labels). Schedule stated by the source: “Study visits at week 0 (baseline), week 6, and week 12 (end of intervention); sample titles encode visit as V1/V2/V3” (time origin: intervention start (randomization/baseline, week 0)); stated follow-up 3 mo.

D010D010: day 0D010: day 42D010: day 84D013D013: day 0D013: day 42D013: day 84D014D014: day 0D014: day 42D014: day 84D015D015: day 0D015: day 42D015: day 84D016D016: day 0D016: day 42D016: day 84D017D017: day 0D017: day 42D017: day 84D018D018: day 0D018: day 42D018: day 84D020D020: day 0D020: day 42D020: day 84D022D022: day 0D022: day 42D022: day 84D023D023: day 0D023: day 42D023: day 84D024D024: day 0D024: day 42D024: day 84D025D025: day 0D025: day 42D025: day 84D026D026: day 0D026: day 42D026: day 84D027D027: day 0D027: day 42D027: day 84D028D028: day 0D028: day 42D028: day 84D029D029: day 0D029: day 42D029: day 84D032D032: day 0D032: day 42D032: day 84D033D033: day 0D033: day 42D033: day 84D034D034: day 0D034: day 42D034: day 84D035D035: day 0D035: day 42D035: day 84D036D036: day 0D036: day 42D036: day 84D037D037: day 0D037: day 42D037: day 84D038D038: day 0D038: day 42D038: day 84D039D039: day 0D039: day 42D039: day 84D04D04: day 0D04: day 42D04: day 84D041D041: day 0D041: day 42D041: day 84D042D042: day 0D042: day 42D042: day 84D043D043: day 0D043: day 42D043: day 84D044D044: day 0D044: day 42D044: day 84D046D046: day 0D046: day 42D046: day 84D047D047: day 0D047: day 42D047: day 84D048D048: day 0D048: day 42D048: day 84D050D050: day 0D050: day 42D050: day 84D051D051: day 0D051: day 42D051: day 84D052D052: day 0D052: day 42D052: day 84D053D053: day 0D053: day 42D053: day 840 d21 d42 d2 mo3 mo

Each row is one person (36 shown of 148); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition
Blautia_A 7.0%Prevotella 5.4%Bacteroides 5.3%Bifidobacterium 5.3%Roseburia 4.8%Faecalibacterium 4.6%Phocaeicola 4.1%Ruminococcoides 4.1%Collinsella 3.3%Mediterraneibacter 2.3%Gemmiger 2.0%Alistipes 1.8%not assigned to a genus 4.5%other genera 45.5%

Genera, mean relative abundance over 389 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country430 100%430
health_condition430 100%430
subject_id423 98%423
antibiotic_exposure430 100%430
health_condition_detail430 100%430
intervention430 100%430
medication430 100%430
medication_detail430 100%430
timepoint_label430 100%430
diet425 99%425
diet_detail425 99%425
intervention_detail425 99%425
Papers (1)
  • Protein supplementation changes gut microbial diversity and derived metabolites in subjects with type 2 diabetes. 2023 PMID 37599833 PMC10432813 own_data
Details
Archive description

shotgun metagenomics data from participants in a multi-center, randomized controlled isocaloric protein intervention with 152 participants that were randomized to follow either a HP (n=79) or LP (n=73) diet for 12 weeks.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by sonnet_x2 with confidence 0.75. Assay shotgun_dna.

  • host run.scientific_name · “human gut metagenome”
  • body site run.scientific_name · “human gut metagenome”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMEA114212908antibiotic_exposurenoR30.70paper.fulltext.methods_resultsExclusion criteria were: use of insulin therapy, antibiotic usage within the last three months
SAMEA114212908countryFRR10.90sample.attr.geographic_location_country_and_or_seaFrance
SAMEA114212908diettherapeutic_or_study_dietR10.90biosample.attribute:special_dietLow protein diet 0 Weeks
SAMEA114212908diet_detailLow protein diet 0 WeeksR10.90biosample.attribute:special_dietLow protein diet 0 Weeks
SAMEA114212908health_conditiontype2_diabetesR30.70paper.fulltext.methods_resultsThis study recruited non-insulin dependent individuals with T2D.
SAMEA114212908health_condition_detailnon-insulin dependent individuals with T2D, defined by the American Diabetes Association, on stable metformin ≥3 monthsR30.70paper.fulltext.methods_resultsThis study recruited non-insulin dependent individuals with T2D.
SAMEA114212908interventionno_interventionR10.80biosample.attribute:special dietspecial diet: Low protein diet 0 Weeks
SAMEA114212940interventionno_interventionR10.85biosample.attribute:special_dietNA 0 Weeks
SAMEA114212908intervention_detailbaseline before low-protein diet (0 weeks)R10.80biosample.attribute:special dietspecial diet: Low protein diet 0 Weeks
SAMEA114212908medicationmetforminR30.70paper.fulltext.methods_resultsAll subjects were on stable metformin therapy and a subset also used other diabetes lowering drugs
SAMEA114212908medication_detailstable use of metformin for ≥3 months, first-line antidiabetic drugR30.70paper.fulltext.methods_resultsAll subjects were on stable metformin therapy and a subset also used other diabetes lowering drugs
SAMEA114212908subject_idD010R10.70sample.name_rule:aliasD010_V1
SAMEA114212908timepoint_labelweek 0R10.85biosample.attribute:special_dietLow protein diet 0 Weeks
Sequencing

430 runs over 430 samples · mean 6.27 Gbp per run (median 6.19 Gbp, total 2,698.13 Gbp; 430 runs with a base count) · layout PAIRED 430 · platform ILLUMINA 430 · models Illumina NovaSeq 6000 (430) · 90% of runs with a Sandpiper profile · first public 2024-10-07

Authors (0)

No author record.

Downloads

PRJEB56830.csv.gz (12.3 KB) · parquet (87.7 KB) — all 430 samples, every field with route and confidence · PRJEB56830_determinations.csv.gz (39.9 KB) — 5,138 evidence rows

Samples (430 · every field this project has values for · hover a cell for its source)
Loading the sample table…